Clinical predictors of bioterrorism-related inhalational anthrax
- PMID: 15288744
- DOI: 10.1016/S0140-6736(04)16769-X
Clinical predictors of bioterrorism-related inhalational anthrax
Abstract
Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.
Comment in
-
Anthrax and bioterrorism: are we prepared?Lancet. 2004 Jul 31-Aug 6;364(9432):393-5. doi: 10.1016/S0140-6736(04)16779-2. Lancet. 2004. PMID: 15288719 No abstract available.
-
Clinical predictors of bioterrorism-related inhalational anthrax.Lancet. 2005 Jan 15-21;365(9455):214-5; author reply 215. doi: 10.1016/S0140-6736(05)17737-X. Lancet. 2005. PMID: 15652599 No abstract available.
-
Clinical predictors of bioterrorism-related inhalational anthrax.Lancet. 2005 Jan 15-21;365(9455):214; author reply 215. doi: 10.1016/S0140-6736(05)17736-8. Lancet. 2005. PMID: 15652600 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
